The Scientific Advisory Team at Ocugen is responsible for providing expert guidance on the scientific and technical aspects of gene therapy research and development. Composed of experienced scientific advisors and a senior scientist, the team evaluates research strategies, reviews data, and ensures alignment with industry standards, ultimately supporting the advancement of innovative treatments for blindness diseases and contributing to vaccine development efforts.
Bruce D. Forrest
Scientific Advisor
Carl D. Regillo
Scientific Advisor
Catherine Pachuk
Scientific Advisor
David Boyer
Scientific Advisor
David Fajgenbaum
Scientific Advisor
Geeta Lalwani
Scientific Advisor
Harvey Rubin
Scientific Advisor
Mark Pennesi
Scientific Advisor
Satish Chandran
Scientific Advisor
Susan Weiss
Scientific Advisor
View all